As some recent studies have suggested that the PMT process following radiation or chemotherapy treatment contributes to the development of increasingly aggressive GBM8,19,30, we wondered whether PPARγ overexpression and activation could suppress the MES GBM phenotype. The gene discussed is PPARG; the disease is glioblastoma.